← FDA Drug Approvals (Drugs@FDA)

BUDESONIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM · Approved 2021-04-14

Drug application

FDA Application #

ANDA211922

Application type

Abbreviated New Drug Application (Generic)

Brand name

BUDESONIDE

Generic name

BUDESONIDE

Active ingredients

BUDESONIDE

Dosage form

SUSPENSION

Route

INHALATION

Marketing status

Prescription

Sponsor

SUN PHARM

Manufacturer

Sun Pharmaceutical Industries, Inc.

First approval

2021-04-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown